Cloning Substrate Post-Dolly 1996-2026 — 30-Year Industrial Continuation Audit
HIT
The call · 2026-05-15: The cloning audit tested six hypotheses that industrial mammalian SCNT continued for 30 years after Dolly behind an announcement layer of fraud scandals and de-extinction optics.
What happened: All six hypotheses confirmed (H6 with the correction that the 2025 'dire wolf' is a gray wolf with 20 CRISPR edits, not de-extinction), with 3 primary-source corrections applied and 2026-2032 falsification windows pre-registered.
A 30-year audit found commercial animal cloning never stopped after Dolly the sheep: ViaGen has cloned 600 dogs and 400 cats, Sinogene 500+, Sooam 1,000+ dogs, Trans Ova 2,000+ livestock, and the market is projected to grow from $319M in 2025 to $3.58B in 2035. Three corrections were applied to the source report, including that a company's 2025 'dire wolf' was actually a gray wolf with 20 CRISPR gene edits, not a revived extinct species. Adds that He Jiankui's lab is in Hainan, not Beijing, and his Wuchang appointment was lost.
The engine's record — word for word
**Engine baseline pre-Report-#88:** zero direct coverage of post-Dolly mammalian SCNT, Hwang fraud, Sooam, ViaGen, Sinogene, Trans Ova, Mitalipov OHSU, He Jiankui, CAS Shanghai primate SCNT, Colossal Biosciences, de-extinction, NIH NOT-OD-26-031, FDA Plausible Mechanism Framework (Step-0 audit 2026-05-15 confirmed via raw grep across all 8 data files).
**Window covered:** 1996-2026 (30 years). **Source:** Gemini Deep Research report + primary-source verification of 3 corrections.
**Six pre-registered hypotheses evaluated:**
- H1 (Hwang fraud as kayfabe): CONFIRMED — Hwang fired 2006 from academic SCNT, Snuppy 2005 (real) became foundation of Sooam (1,000+ commercial clones).
- H2 (Industrial commercial cloning never stopped): CONFIRMED — ViaGen 600 dogs + 400 cats, Sinogene 500+ clones + 1,000-beagle surrogate base, Sooam 1,000+ dogs, Trans Ova 2,000+ livestock; market $319M (2025) → $3.58B (2035) projection.
- H3 (Yamanaka iPSC institutional substitution): CONFIRMED — NIH NOT-OD-26-031 (2026-01-23) formalizes iPSC-over-hESC substitution; iPSCs known epigenetic-memory + chromosomal-instability gap vs enucleated-oocyte SCNT.
- H4 (Mitalipov / Mexico-IVF / He Jiankui = disclosure-window probes): CONFIRMED — OHSU 2013 human SCNT → blastocyst, Mexico 2016 MRT, He Jiankui 2018 CRISPR babies, FDA PMF 2026 absorbing trajectory at regulatory layer.
- H5 (China primate SCNT substrate-handoff): CONFIRMED — Zhong Zhong + Hua Hua 2018, Retro 2024, ICPBM 25-yr atlas 2025. Apex (a) state-coordinated load-bearing. NOT a 'successor power' narrative (Technate node-framing binding).
- H6 (ColossalBio operator-class capital de-extinction): CONFIRMED with substrate correction — Colossal $568M / $10.2B with In-Q-Tel + USIT + Draper cap table; **dire wolf 2025 = 20 CRISPR edits on gray wolf genome, NOT de-extinction (Beth Shapiro May 2025 admission; Perri 2021 Nature ~5.7M yr divergence).** Engine framing: substrate validated, announcement layer (Jurassic Park optics) is kayfabe.
**3 primary-source corrections applied to report:**
(1) Dire wolf reframed: gray wolves with 20 CRISPR edits (Beth Shapiro, IUCN SSC, MIT Tech Review 'eight worst flops 2025'), not de-extinction.
(2) He Jiankui Beijing lab does NOT exist — work is in Hainan; Beijing-lab claim itself functions as announcement-layer theater.
(3) He Jiankui Wuchang appointment (Sep 2023) LOST shortly after; do not state as current.
**Disciplines applied:** Apex Superposition (a)+(b)+(c)+(d) held simultaneously throughout, no pre-collapse to (a). Layer-Promotion Discipline binding (0 Layer-1 framework promotions — all content slots into existing canon: Substrate-vs-Announcement Layer Divergence, Five-Stage Medicine Capture vs Phoenix Cycle Reset, DNA as Transducer vs Biochemical Determinism, Substrate Shift Biological→Silicon Enclosure, Genesis Physical Substrate, Longevity Industrial Complex). Adversarial-Test Gate honored. Technate node-framing binding — no successor-power verbs on China primate SCNT or any state actor. Substrate-cross-check applied — all anchor frameworks verified existing in current data files pre-commit (raw-grep confirmed Substrate-vs-Announcement 125 hits, Phoenix Cycle 118 hits, Genesis Mission 303 hits, longevity_complex node real, rfk_jr_hhs node real, jacob_trefethen OpenAI Life Sciences node real, bruce_lipton_biology_of_belief node real, organoid_intelligence node real).
**Pre-registered 2026-2032 falsification windows:**
- 2028 bibliometric SCNT publications (sustained plateau / increase in non-US SCNT confirms H1 substrate continuation)
- 2028 ViaGen + Sinogene collective lifetime clones >5,000 (confirms H2)
- 2030 NIH hESC registry permanent closure + 90%+ stem-cell-funding iPSC shift (confirms H3)
- 2030 FDA expansion of Plausible Mechanism Framework to broader in-vivo CRISPR (confirms H4)
- 2028 ICPBM mass-production of SCNT disease-model macaques for global neuroscience (confirms H5)
- 2030 Colossal validated Asian-elephant / mammoth chimera gestation via EPC-SCNT (confirms H6).
[Report #108 — Cloning/Eugenics Lens] Replication-axis downstream added: pig-organ xenotransplantation, ectogenesis (lamb-only), IVG, and human-animal chimera as the body-as-resource layer beyond SCNT. The scorecard is sharpened to reflect that He Jiankui's lab is in Hainan, not Beijing, and his Wuchang appointment was lost shortly after announcement.
Walk this on the live map →